Inventiva (IVA) Total Liabilities (2018 - 2025)
Inventiva's (IVA) quarterly Total Liabilities came in at $323.6 million in Q4 2025, up 34.24% year-on-year from $241.1 million in Q4 2024, and down 99.85% quarter-over-quarter from $212.7 billion in Q2 2025.
Inventiva (IVA) Total Liabilities (2018 - 2025) Analysis & Trends
Inventiva's Total Liabilities history runs 8 years deep, the most recent figure standing at $323.6 million for Q4 2025.
- On a quarterly basis, Total Liabilities rose 34.24% year-over-year to $323.6 million in Q4 2025; TTM through Dec 2025 was $323.6 million, a 34.24% increase from a year earlier, with the FY2025 full-year figure at $323.6 million, up 34.24% from the prior year.
- Total Liabilities declined to $323.6 million in Q4 2025 per IVA's latest filing, from $212.7 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $212.7 billion in Q2 2025 and bottomed at $115662.5 in Q2 2022.
- The 5-year median for Total Liabilities is $72.0 million (2022), against an average of $19.4 billion.
- Across the five-year window, Total Liabilities plunged 99.92% in 2022 and jumped 1026632.07% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $37.9 million in 2021, then jumped by 89.92% to $72.0 million in 2022, then soared by 51.91% to $109.3 million in 2023, then jumped by 120.56% to $241.1 million in 2024, then jumped by 34.24% to $323.6 million in 2025.
- Per Business Quant, the three latest IVA Total Liabilities figures stand at $323.6 million (Q4 2025), $212.7 billion (Q2 2025), and $241.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 323.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 323.64 Mn |
| Jun 30, 2025 | 212.65 Bn |
| Dec 31, 2024 | 241.09 Mn |
| Jun 30, 2024 | 20.71 Mn |
| Dec 31, 2023 | 109.31 Mn |
| Oct 11, 2023 | 34.96 Mn |
| Dec 31, 2022 | 71.96 Mn |
| Jun 30, 2022 | 115,662.54 |
| Dec 31, 2021 | 37.89 Mn |
| Jun 30, 2021 | 141.16 Mn |
| Mar 31, 2021 | 27.04 Mn |
| Dec 31, 2020 | 24.06 Mn |
| Jun 30, 2020 | 75.70 Mn |
| Dec 31, 2019 | 63.05 Mn |
| Dec 31, 2018 | 91.10 Mn |